Hamilton Lane Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Hamilton Lane Advisors’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,900	Closed	-$1.63M	–	35
2023 Q3	$1.63M	Hold	24,900	–	–	0.92%	17
2023 Q2	$1.45M	Hold	24,900	–	–	0.64%	28
2023 Q1	$1.54M	Hold	24,900	–	–	0.51%	25
2022 Q4	$1.58M	Hold	24,900	–	–	0.57%	26
2022 Q3	$1.81M	Hold	24,900	–	–	0.66%	23
2022 Q2	$1.69M	Hold	24,900	–	–	0.66%	22
2022 Q1	$2.26M	Hold	24,900	–	–	0.51%	22
2021 Q4	$2.27M	Hold	24,900	–	–	0.29%	32
2021 Q3	$2.02M	Sell	24,900 -1,503	-6%	-$126K	0.34%	35
2021 Q2	$2.46M	Sell	26,403 -3,690	-12%	-$358K	0.77%	34
2021 Q1	$3.22M	Buy	30,093 +19,422	+182%	+$2.02M	1.05%	24
2020 Q4	$931K	Buy	+10,671	New	+$754K	0.35%	35

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hamilton Lane Advisors's NARI Position: Q4 2023 in Review

Hamilton Lane Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2023, closing a stake of 24,900 shares — an estimated $1.63M sold.

Hamilton Lane Advisors first reported a position in NARI in Q4 2020 and held it in 12 quarters. The position peaked at $3.22M in Q1 2021. 252 funds tracked by Wall St. Rank hold NARI as of Q4 2023.

Hamilton Lane Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Hamilton Lane Advisors sold 24,900 Inari Medical, Inc. Common Stock shares in Q4 2023, an estimated $1.63M.
Hamilton Lane Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
Hamilton Lane Advisors's Inari Medical, Inc. Common Stock position peaked at $3.22M in Q1 2021.
252 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2023.

Based on Hamilton Lane Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.